BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31227996)

  • 1. Psychometric Properties of the MICRA Questionnaire in Portuguese Individuals Carrying SDHx Mutations.
    Martins RG; Carvalho IP
    J Cancer Educ; 2020 Oct; 35(5):1026-1033. PubMed ID: 31227996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pheochromocytoma and paraganglioma genetic testing: Psychological impact.
    Martins RG; Carvalho IP
    Health Psychol; 2020 Oct; 39(10):934-943. PubMed ID: 32628029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hereditary pheochromocytoma and paraganglioma: screening and follow-up strategies in asymptomatic mutation carriers].
    Vermalle M; Tabarin A; Castinetti F
    Ann Endocrinol (Paris); 2018 Sep; 79 Suppl 1():S10-S21. PubMed ID: 30213301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic testing for pheochromocytoma and paraganglioma: SDHx carriers' experiences.
    Martins RG; Carvalho IP
    J Genet Couns; 2021 Jun; 30(3):872-884. PubMed ID: 33604970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and spectrum of SDHx mutations in pheochromocytoma and paraganglioma in patients from Belgium: an update.
    Persu A; Lannoy N; Maiter D; Mendola A; Montigny P; Oriot P; Vinck W; Garin P; Hamoir M; Vikkula M
    Horm Metab Res; 2012 May; 44(5):349-53. PubMed ID: 22566194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators.
    Gimenez-Roqueplo AP; Caumont-Prim A; Houzard C; Hignette C; Hernigou A; Halimi P; Niccoli P; Leboulleux S; Amar L; Borson-Chazot F; Cardot-Bauters C; Delemer B; Chabolle F; Coupier I; Libé R; Peitzsch M; Peyrard S; Tenenbaum F; Plouin PF; Chatellier G; Rohmer V
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E162-73. PubMed ID: 23162105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germinal defects of SDHx genes in patients with isolated pituitary adenoma.
    Mougel G; Lagarde A; Albarel F; Essamet W; Luigi P; Mouly C; Vialon M; Cuny T; Castinetti F; Saveanu A; Brue T; Barlier A; Romanet P
    Eur J Endocrinol; 2020 Oct; 183(4):369-379. PubMed ID: 32621582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A founder SDHB mutation in Portuguese paraganglioma patients.
    Martins RG; Nunes JB; Máximo V; Soares P; Peixoto J; Catarino T; Rito T; Soares P; Pereira L; Sobrinho-Simões M; Santos AP; Couto J; Henrique R; Matos-Loureiro J; Dias P; Torres I; Lima J
    Endocr Relat Cancer; 2013 Dec; 20(6):L23-6. PubMed ID: 24092654
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of metastatic pheochromocytoma and paraganglioma in
    Lee H; Jeong S; Yu Y; Kang J; Sun H; Rhee JK; Kim YH
    J Med Genet; 2020 Apr; 57(4):217-225. PubMed ID: 31649053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Succinate-Dehydrogenase Deficient Paragangliomas/Pheochromocytomas: Genetics, Clinical Aspects and Mini- Review.
    Rusyn L; Kohn B
    Pediatr Endocrinol Rev; 2017 Mar; 14(3):312-325. PubMed ID: 28508602
    [No Abstract]   [Full Text] [Related]  

  • 11. Presymptomatic genetic testing in minors at risk of paraganglioma and pheochromocytoma: our experience of oncogenetic multidisciplinary consultation.
    Lahlou-Laforêt K; Consoli SM; Jeunemaitre X; Gimenez-Roqueplo AP
    Horm Metab Res; 2012 May; 44(5):354-8. PubMed ID: 22517555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translation and Validation of the "7-Item Eustachian Tube Dysfunction Questionnaire" to European Portuguese (PT).
    Menezes AS; Ribeiro DC; Guimarães JR; Costa I; Moreira F; Dias L
    Acta Med Port; 2020 Mar; 33(3):191-197. PubMed ID: 31958396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SDHx-related pheochromocytoma/paraganglioma - genetic, clinical, and treatment outcomes in a series of 30 patients from a single center.
    Donato S; Simões H; Pinto AT; M Cavaco B; Leite V
    Endocrine; 2019 Aug; 65(2):408-415. PubMed ID: 31104306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cultural adaptation and psychometric validation of the Portuguese breakthrough pain assessment tool with cancer patients.
    Bernardes SF; Matos M; Mourão S; Vauclair CM
    Scand J Pain; 2021 Oct; 21(4):688-695. PubMed ID: 33930265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma.
    Buffet A; Burnichon N; Favier J; Gimenez-Roqueplo AP
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101416. PubMed ID: 32295730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic Urine Profile: Searching for New Biomarkers of SDHx-Associated Pheochromocytomas and Paragangliomas.
    Martins RG; Gonçalves LG; Cunha N; Bugalho MJ
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5467-5477. PubMed ID: 31504671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients.
    Cascón A; Inglada-Pérez L; Comino-Méndez I; de Cubas AA; Letón R; Mora J; Marazuela M; Galofré JC; Quesada-Charneco M; Robledo M
    Endocr Relat Cancer; 2013 Jun; 20(3):L1-6. PubMed ID: 23404858
    [No Abstract]   [Full Text] [Related]  

  • 18. Pituitary adenoma with paraganglioma/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice.
    Xekouki P; Szarek E; Bullova P; Giubellino A; Quezado M; Mastroyannis SA; Mastorakos P; Wassif CA; Raygada M; Rentia N; Dye L; Cougnoux A; Koziol D; Sierra Mde L; Lyssikatos C; Belyavskaya E; Malchoff C; Moline J; Eng C; Maher LJ; Pacak K; Lodish M; Stratakis CA
    J Clin Endocrinol Metab; 2015 May; 100(5):E710-9. PubMed ID: 25695889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of the oncometabolite succinate in SDHx-mutation carriers.
    Eijkelenkamp K; Osinga TE; Links TP; van der Horst-Schrivers ANA
    Clin Genet; 2020 Jan; 97(1):39-53. PubMed ID: 30977114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome.
    Patócs A; Lendvai NK; Butz H; Liko I; Sapi Z; Szucs N; Toth G; Grolmusz VK; Igaz P; Toth M; Rácz K
    Pathol Oncol Res; 2016 Oct; 22(4):673-9. PubMed ID: 26960314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.